Related Experiment Video
Updated: Mar 27, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
25.2K
Guidelines for genomic array analysis in acquired haematological neoplastic disorders.
Jacqueline Schoumans1, Javier Suela2, Ros Hastings3
1Unité De Génétique Du Cancer, Service De Génétique Médicale, Centre Hospitalier Universitaire Vaudois, Lausanne, CH-1011, Switzerland.
Genes, Chromosomes & Cancer
|January 17, 2016
Summary
Genetic profiling using microarray technologies aids in neoplasia evaluation and treatment prediction. This study presents standardization criteria for interpreting complex genomic profiles in diagnostic laboratories.
Area of Science:
- Genomics
- Oncology
- Molecular Diagnostics
Background:
- Genetic profiling is crucial for evaluating neoplasia, predicting prognosis, and assessing therapy response.
- Microarray technologies like array comparative genomic hybridization (aCGH) and single-nucleotide polymorphism (SNP) arrays are increasingly used in diagnostics for hematological malignancies and solid tumors.
- These array-based genomic tests can serve as complementary or standalone diagnostic tools.
Purpose of the Study:
- To address the challenge of presenting complex genomic profiles from microarray analyses in a comprehensive and readable manner.
- To provide diagnostic laboratories with standardization and minimum criteria for the clinical interpretation and reporting of acquired genomic abnormalities detected by arrays in neoplastic disorders.
Main Methods:
- Review and synthesis of current practices in array-based genomic profiling for neoplastic disorders.
- Development of standardized criteria for interpretation and reporting of genomic abnormalities.
Main Results:
- Established minimum criteria for the clinical interpretation of array-detected genomic abnormalities in neoplasia.
- Proposed a framework for standardized reporting to enhance clarity and consistency in diagnostic laboratories.
Conclusions:
- Standardized interpretation and reporting are essential for effectively utilizing complex genomic data from microarray analyses in clinical practice.
- Implementation of these criteria will improve the diagnostic utility and clinical relevance of genetic profiling in oncology.
